| CTRI Number |
CTRI/2024/10/075051 [Registered on: 10/10/2024] Trial Registered Prospectively |
| Last Modified On: |
18/02/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Other (Specify) [safety and efficacy study] |
| Study Design |
Randomized, Crossover Trial |
|
Public Title of Study
|
An exploratory clinical study to evaluate changes in lipid profile in healthy human subjects following consumption of potato chips fried in cottonseed oil versus Refined Palmolein oil. |
|
Scientific Title of Study
|
An Exploratory, Interventional, Prospective, Randomized, Cross-Over, Two-Arm, Clinical Study to evaluate the safety of Test Food(s) (i.e. Potato Chips Fried in Cotton Seed Oil Vs. Potato Chips Fried in Refined Palmolein Oil) on lipid profiles in Healthy Human Subjects. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NB240050-HH 1.0, 19Sep 24 |
Protocol Number |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Jigar Patel |
| Designation |
Principal Investigator |
| Affiliation |
NovoBliss Research Private Limited |
| Address |
NovoBliss Research Pvt. Ltd.
Office# A - 206, 2nd Floor,
Shaligram Lakeview Business Complex,
Nr. Vaishnodevi Circle, Khoraj,
Gandhinagar
Gandhinagar GUJARAT 382421 India |
| Phone |
9909013286 |
| Fax |
|
| Email |
consultant@novobliss.in |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Nayan Patel |
| Designation |
Sub- Investigator |
| Affiliation |
NovoBliss Research Private Limited |
| Address |
NovoBliss Research Pvt. Ltd.
Office# A - 206, 2nd Floor,
Shaligram Lakeview Business Complex,
Nr. Vaishnodevi Circle, Khoraj,
Gandhinagar
Gandhinagar GUJARAT 382421 India |
| Phone |
9909013286 |
| Fax |
|
| Email |
dr.nayan@novobliss.in |
|
Details of Contact Person Public Query
|
| Name |
Maheshvari Patel |
| Designation |
Director Operations and Strategic Management |
| Affiliation |
NovoBliss Research private Limited |
| Address |
NovoBliss Research Pvt. Ltd.
Office# A - 206, 2nd Floor,
Shaligram Lakeview Business Complex,
Nr. Vaishnodevi Circle, Khoraj,
Gandhinagar
Gandhinagar GUJARAT 382421 India |
| Phone |
9909013286 |
| Fax |
|
| Email |
maheshvari@novobliss.in |
|
|
Source of Monetary or Material Support
|
| Tirupati agrotech private limited
7th Floor, popular house, ashram road
Ahmedabad, Gujarat 380009
|
|
|
Primary Sponsor
|
| Name |
Tirupati agrotech private limited |
| Address |
7th floor, popular house, ashram road
Ahmedabad, Gujarat 380009
|
| Type of Sponsor |
Other [Food and agrotech] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Nayan Patel |
NovoBliss Research Pvt. Limited |
clinical trial department,
office A 206, NovoBliss
Research Pvt. Limited
Office# A - 206, 2nd
Floor, Shaligram
Lakeview Business
Complex, Nr.
Vaishnodevi Circle,
Khoraj, Gandhinagar
382421, Gujarat – India
Gandhinagar
GUJARAT Gandhinagar GUJARAT |
9909013286
dr.nayan@novobliss.in |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| ACEAS – Independent Ethics Committee, |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
Healthy Human Volunteers |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Nil |
NA |
| Intervention |
Test Food A: Potato Chips fried in Cotton Seed oil |
Mode of Usage: Subjects will consume 100 g of potato chips at morning breakfast, following at least 12 hours fasting period, with the intake to be completed within 15 minutes. Route of
Administration- Orally Frequency - once a day Dose: 100 g of potato chips Dosage Form: solid Day of Administration: Day 02 and Day 05 |
| Intervention |
Test Food B: Potato Chips fried in Refined Palmolein oil |
Mode of Usage: Subjects will consume 100 g of potato chips at morning breakfast, following at least 12 hours fasting period, with the intake to be completed within 15 minutes. Route of Administration- Orally Frequency - once a day Dose: 100 g of potato chips Dosage Form: solid Day of Administration: Day 02 and Day 05 |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
1)Age: Adults: 18 to 65 years (both inclusive) at the time of consent 2)Sex: Adults (males and non-pregnant or non-lactating females). 3)Females of childbearing potential should have a self-reported negative urine pregnancy test. 4)Subjects are generally in good general health as determined from a recent medical history, except for the atopic dermatitis.5)Subjects having stable weight for greater or equal to 3 month before the study. 6)Subjects are not allowed to participate in any other study until this study is complete. 7)Subjects must be willing and able to follow the study directions and to return for all specified visits with the subject.8)Subjects willing to follow the study instruction and restrictions. 9)Subject must read, sign, and receive a copy of Informed Consent prior to initiate of study procedures.
|
|
| ExclusionCriteria |
| Details |
1)Subjects who use of lipid-lowering medication.2)Subjects having history of CVD. 3)Subjects having type 1 or type 2 diabetes.4)Subjects having hypertension. 5)Subjects having sensitivity towards taste and smell of oil. 6)Subjects having history of gastrointestinal disorders. 7)Subjects that are pregnant and/or breastfeeding. 8)Change in current prescriptions (within 4 weeks of screening) or new and/or additional prescriptions for dyslipidaemia (within 4 weeks of screening) or during the study. 9)The subject must not have participated in a clinical study within 4 weeks prior to the screening visit of this study. 10)Any other condition which could warrant exclusion from the study, as per the study physician. 11)History of chronic illness which may influence the study results.
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Centralized |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
To evaluate the safety of the test foods in terms of
1. change in lipid profile before and after consumption of the food
2.change in CBC, biochemistry, random blood sugar, uric acid, urinalysis before and after consumption of the test food
|
Within 7 days from Day 01, after 12 hours of fasting on Day 01 and further 04 hours of fasting at Day 01, and on Day 02 and Day 05
2.Within 07 days from Day 01, and on Day 05
|
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Nil |
NA |
|
|
Target Sample Size
|
Total Sample Size="34" Sample Size from India="34"
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="0" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
21/10/2024 |
| Date of Study Completion (India) |
Date Missing |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="0" Months="0" Days="7" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
Modification(s)
|
This
exploratory, interventional, prospective, randomized, cross-over, two-period,
two-arm clinical trial evaluated the safety and impact of potato chips
deep-fried in refined Cottonseed oil versus potato chips deep fried in refined Palmolein
oil on lipid profiles in healthy adults aged 18 to 65 years. A total of 34
participants were enrolled and completed the study, which was registered with
the Clinical Trial Registry of India (CTRI/2024/10/075051) on October 10, 2024.
Subjects were screened by the NovoBliss Research screening department following
Ethics Committee approved protocol standards and internal standard operating
procedures.
Study
Procedure and Methodology
The study was
conducted over three distinct periods to assess the effects of Cottonseed oil
consumption on lipid metabolism. Each period followed a structured protocol,
including fasting conditions, sample collection, and data analysis, ensuring a
rigorous and standardized approach.
Day 01 (Period
I): Baseline Assessment
On the first
day of the study, subjects arrived at the clinical site after a mandatory
12-hour overnight fast to ensure accurate baseline lipid profile measurements.
Fasting blood samples (0-hour) were collected to establish baseline lipid
levels before any dietary intervention. A second blood sample was drawn 4 hours
post-fasting to evaluate natural lipid metabolism in the absence of any test
food intake. Throughout the period, any adverse events (AEs) and concomitant
medications were carefully documented to ensure participant safety and data
integrity.
Day 02 (Period
II): Test Food Consumption and Lipid Profile Evaluation
Following
another 12-hour overnight fast, subjects returned to the clinical site for
their second round of assessments. Baseline fasting lipid profile samples were
collected before administering the assigned test food, determined based on a
randomized allocation. Subjects then consumed the test food as per the study
protocol. After ingestion, a post-consumption lipid profile sample was
collected 4 hours later to assess acute changes in lipid metabolism. Any
adverse events or medical concerns were closely monitored and documented
throughout the process.
Day 05 (Period
III): Washout Period and Repeat Assessment
After a
three-day washout period, designed to minimize any carryover effects from the
previous test food intake, subjects underwent a final assessment. Procedures
from Period II were repeated, starting with a 12-hour overnight fast, followed
by baseline lipid profile collection. Participants again consumed the assigned
test food, and post-consumption blood samples were collected 4 hours later to
measure lipid profile variations. Additionally, safety laboratory parameters,
including hematological and biochemical markers, were assessed to ensure no
adverse effects from dietary intervention.
Data Analysis
and Statistical Considerations
All collected
raw data underwent a thorough quality review before proceeding to statistical
analysis. SPSS (Version 29.0.1.0(171)) and Microsoft Excel were used for data
processing and interpretation. Statistical significance was set at a 5% level
(p < 0.05) to ensure a robust and reliable evaluation of the findings. The
structured methodology ensured that the results were both scientifically
rigorous and clinically relevant, providing valuable insights into the effects
of Cottonseed oil consumption on lipid metabolism.
The findings
of this study highlight the potential health benefits and safety of
incorporating refined Cottonseed oil into the diet, particularly through its
use in deep-frying potato chips. A single consumption of Cottonseed oil
demonstrated a favorable impact on lipid profile modulation, evidenced by a significant
increase in HDL cholesterol levels and a slight reduction in LDL cholesterol
levels—both key factors in maintaining optimal cardiovascular health.
Given these
promising results, it can be hypothesized that the exclusive and prolonged use
of Cottonseed oil may yield more robust clinical data, further reinforcing its
potential as a heart-friendly dietary oil. In-vitro analysis of Cottonseed oil
revealed its high linoleic acid content, which has been associated with
improved cardiovascular health, reduced inflammation, and better overall fat
quality. These attributes make Cottonseed oil a superior choice for frying,
particularly when compared to Palmolein oil, which is often linked to higher
saturated fat content and less favorable lipid metabolism effects.
Importantly,
the study also found that the consumption of Cottonseed oil did not lead to any
significant alterations in hematological, biochemical, or renal parameters,
confirming its safety for regular dietary use. The observed changes in lipid
profiles remained stable and within the normal laboratory range, suggesting no
adverse effects on overall health.
Based on these
findings, potato chips fried in Cottonseed oil emerge as a safe and potentially
beneficial option for consumption, especially for individuals seeking to
support cardiovascular health. Future studies with extended durations and
larger sample sizes may provide deeper insights into its long-term benefits and
clinical significance. |